Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma

Sequencing-based counting and fragment-size profiling of plasma EBV DNA improved the performance of population screening for nasopharyngeal carcinoma, building on the 2017 NEJM PCR screening study.

Proc Natl Acad Sci U S APubMed 29760067DOI 10.1073/pnas.1804184115